What is Treatment Monitoring in Cancer?
Treatment monitoring in cancer refers to the ongoing process of assessing how well a treatment is working in managing or eradicating cancer. This involves regularly evaluating the patient's response to therapy and determining if the current treatment plan needs adjustment to improve outcomes or minimize side effects.
Imaging Techniques: CT scans, MRIs, and PET scans are commonly used to visualize the tumor's response to treatment.
Biomarkers: Blood tests to measure specific proteins or genetic markers that indicate the presence and activity of cancer.
Physical Exams: Regular physical examinations to check for changes in the tumor size or new symptoms.
Biopsies: Taking tissue samples to analyze the cancer cells' response at a molecular level.
What are Common Biomarkers?
Biomarkers are biological molecules that indicate the presence or progression of cancer. Common biomarkers include:
CA-125: Often used to monitor ovarian cancer.
PSA: Used in monitoring prostate cancer.
HER2: Important in breast cancer treatment.
CEA: Used for colorectal and other cancers.